OG DNA Genetics announced a second licensing agreement with 1933 Industries (OTCQB:TGIFF), a cultivator and producer of cannabis flower and concentrates and manufacturer of hemp-derived CBD wellness products.
The agreement will grant 1933 Industries license to the DNA brand for the production and sale of hemp-derived CBD products. This marks DNA’s first entry into the CBD market. Whereas, the deal allows DNA to take advantage of 1933’s vast distribution network of over 800 retail outlets throughout the U.S.
“We are excited to expand our partnership with 1933, one of leaders in the CBD wellness space,” stated Don Morris, co-founder of DNA Genetics. “It feels good to build on an already strong relationship with a like-minded company committed to putting out the best quality products.”